China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

China’s Commerce Ministry this week said it placed Illumina, the leading maker of next-generation sequencing machines, on its list of “unreliable entities,” part of China’s retaliation ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

On the biopharma side of things, Nvidia is teaming up with DNA sequencing powerhouse Illumina. Illumina will ... organization focusing on biology and machine learning, to develop AI tools to ...

Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays ... Parsortix-based CTC analysis for DNA dual analysis NGS sequencing, enabling analysis of ...

Angle plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, has announced new, successful ...